151. Wearable Cardioverter-Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation
- Author
-
Kovacs, Boldizsar; https://orcid.org/0000-0002-7972-5199, Müller, Flavia, Niederseer, David; https://orcid.org/0000-0003-3089-1222, Krasniqi, Nazmi, Saguner, Ardan M, Duru, Firat; https://orcid.org/0000-0002-4748-0158, Hermann, Matthias; https://orcid.org/0000-0002-0694-7719, Kovacs, Boldizsar; https://orcid.org/0000-0002-7972-5199, Müller, Flavia, Niederseer, David; https://orcid.org/0000-0003-3089-1222, Krasniqi, Nazmi, Saguner, Ardan M, Duru, Firat; https://orcid.org/0000-0002-4748-0158, and Hermann, Matthias; https://orcid.org/0000-0002-0694-7719
- Abstract
BACKGROUND The wearable cardioverter-defibrillator (WCD) has a built-in accelerometer, which allows tracking of patients' physical activity by remote monitoring. It is unclear whether WCD-measured physical activity, step count, and heart rate correlate with established tools for the assessment of cardiopulmonary fitness such as the 6-min walk test (6MWT). OBJECTIVE To correlate measurements of patient physical activity through the WCD with a supervised 6MWT during in-patient cardiac rehabilitation (CR) and to allow their use as surrogate parameters of cardiopulmonary fitness in an out-patient setting. METHODS Consecutive patients with a history of WCD use treated at our center and an in-patient CR following an index hospitalization were included. Baseline characteristics, measurements of WCD accelerometer (median daily step count, median daily activity level), median daily heart rate, and clinically supervised 6MWT at admission and discharge of CR were obtained. RESULTS Forty-one patients with a mean age of 55.5 (±11.5) years were included. Thirty-five patients (85.4%) were male and 28 patients (68%) had a primary prophylactic WCD-indication. The most common underlying heart diseases were ischemic heart disease (24 patients 58.6%) and dilated cardiomyopathy (13 patients, 31.7%). Median CR duration was 20 (IQR 19.75-26.25) days. 6MWT distance increased from a mean of 329 m (±107) to 470 m (±116) during CR (p < 0.0001). The median daily step count and activity level increased significantly, from 5542 steps (IQR 3718-7055) to 8778 (IQR 6229-12,920, p < 0.0001) and median 117 × 10$^{6}$ (IQR 96 × 10$^{6}$-142 × 10$^{6}$) threshold value exceedance (TVE) to 146 × 10$^{6}$ TVE (IQR 110 × 10$^{6}$-169 × 10$^{6}$, p < 0.0001), respectively. The median heart rate was 74.9 bpm (IQR 65.8-84.5) and 70.2 (IQR 64.1-77.3, p = 0.09) at admission and discharge, respectively. Of all three parameters, median daily step count showed the best correlation to the results of the 6MWT at ad
- Published
- 2021